BMRN vs FRSH · P/E 40, rev $1.76B vs P/E 16, rev $466.0M
Biomarin Pharmaceutical Inc (BMRN) versus Freshworks Inc (FRSH) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Freshworks Inc (FRSH) is a software - application company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported FRSH revenue for 2026-06-30 was $466.0M. Net income was -$1.6M. FRSH currently screens at market cap $2.62B and trailing P/E 15.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. FRSH currently screens at market cap $2.62B and trailing P/E 15.5.
Not investment advice. Open the BMRN and FRSH stock pages for the full models.
Not investment advice.